FMC ACO

Accountable Care Organizations Public Reporting Information

ACO NAME & LOCATION

Florida Medical Clinic ACO, LLC
38135 Market Square
Zephyrhills, FL 33542

ACO PRIMARY CONTACT

Chandresh Saraiya, MD, FMC
Florida Medical Clinic, LLC
Chairman
813.712.1645

ORGANIZATIONAL INFORMATION

ACO Participants
Florida Medical Clinic, LLC
FMC Urgent Care, LLC

ACO PARTICIPANTS IN JOINT VENTURES BETWEEN ACO PROFESSIONALS AND HOSPITALS

FMC Urgent Care, LLC

Florida Medical Clinic, LLC

ACO GOVERNING BODY

Juan Cevallos, MD
Voting member
ACO Participant Representative, FMC

Joe Cozzolino, MD
Voting member
ACO Participant Representative, FMC

Gerald Curley, DO
Voting member
ACO Participant Representative, FMC

Joe Delatorre, CEO
Voting member
Other representative

Emilio Dominguez, MD
Voting member
ACO Participant Representative, FMC

Mitch Forman, MD
Voting member
ACO Participant Representative, FMC Urgent Care

Joseph Gallagher
Voting member
Medicare Beneficiary Representative

Paul Gerczuk, MD
Voting member
ACO Participant Representative, FMC

Matthew Hartlage, MD
Voting member
ACO Participant Representative, FMC

Belen Herrero, MD
Voting member
ACO Participant Representative, FMC

Richard Ina, MD
Voting member
ACO Participant Representative, FMC

Chandresh Saraiya, MD
Chairman
Voting member
ACO Participant Representative, FMC

Rohitkumar Vyas, MD
Voting member
ACO Participant Representative, FMC

KEY ACO CLINICAL AND ADMINISTRATIVE LEADERSHIP

Joe Delatorre, CEO
ACO Executive

Dr. Chandresh Saraiya,
Medical Director

Eddine Luma,
Compliance & HIPAA Privacy Officer

Dr. Emilio Dominguez,
Chief Medical Director

ACO COMMITTEES & COMMITTEE LEADERSHIP

Quality and Performance Monitoring Committee

Nancy Finnerty, MD
Chairman

Douglas Baska, DO

Crete Fisher, MD

Joseph Hubaykah, MD

Tracy Mckay, MD

Richard McDonough, MD

Parag Pitroda, MD

Chandresh Saraiya, MD

Joel Sokolik, MD

Gabriel Somori, MD

Compliance Committee

Eddine Luma, Assoc. Director of Clinical Transformation & Compliance & HIPAA Privacy Officer
Chairperson

Christian Alvarez, CFO

Samantha Champagnie, Senior Director

Joe Delatorre, CEO

Emilio Dominguez, MD

Gus Taylor, CAO

Paula VanNorman, Sr. Director of Physician Offices

Community Relations Committee

Chandresh Saraiya, MD, FMC
Chairman

Leigh Walker-Blankenship, ACO Manager, FMC

Sirisha Chalasani, MD, FMC

Ana Z. Torres Alvarez, ACO RN Care Manager, FMC

Heather Tomberlin, ACO LPN Care Manager, FMC

James Judkins, ACO LPN Care Manager, FMC

Traci Belle Simpson, ACO RN Care Manager, FMC

Tanja Cogan, BSW, FMC

Evan Smith, Encompass Home Health

Alysia Dunwoody, RN, Encompass Home Health

Michael Dougherty, RN, Encompass Home Health

Kathy Kondolf-Harmmer, Administrator, Heartland of Zephyrhills

Adam Timer, Heartland of Zephyrhills

Donna Coulter, DON, Royal Oaks

Jake Mitchell, Administrator, Royal Oaks

Rosemary Hartzner, Admissions Director, Royal Oaks

Payton Baker, Heritage Park

Lido Capogrosso, Admissions Director, Heritage Park

Pamela Cafra, Zephyrhills Health & Rehab

Karen Alvarez, CARES Home Health

Rey Basila, PT, Administrator, Mission Home Care

Geri Burke, Care Patrol

Crete Fisher, MD, FMC

Reginald Villaruel, RN, Director of Nursing, Mission Home Care

Florida Medical Clinic ACO Information

ACO Information

TYPES OF ACO PARTICIPANTS THAT FORMED THE ACO

A network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Second Agreement Period First Agreement Period
Performance Year 2017, $4,615,423

Performance Year 2016, $0

 Performance Year 2015, $0

Performance Year 2014, $0

Performance Year 2013, $0

Shared Savings Distribution

Second Agreement Period First Agreement Period
Performance Year 2017
Proportion invested in infrastructure: 10%
Proportion invested in redesigned care processes/resources: 10%
Proportion of distribution to ACO participants: 80%
A: PCP’s 70%
B: Hospitalist and Specialist 30%Performance Year 2016
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A		 Performance Year 2015
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/APerformance Year 2014
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/APerformance Year 2013
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A

PAYMENT RULE WAIVERS

Yes, our ACO does use the SNF 3-Day Rule Waiver.

PREVIOUS YEARS QUALITY PERFORMANCE RESULTS

2012 Reporting Period 2013 Reporting Period 2014 Reporting Period
Measure number Performance Measure ACO Performance Rate Mean Performance Rate for All ACOs ACO Performance Rate Mean Performance Rate for All ACOs ACO Performance Rate Mean Performance Rate for All ACOs
ACO #1 Getting Timely Care, Appointments, and Information 78.12 81.69 78.7 81.48 77.59 80.13
ACO #2 How Well Your Doctors Communicate 88.73 92.84 91.72 92.96 91.46 92.39
ACO #3 Patients’ Rating of Doctor 88.12 91.86 90.02 92.06 91.43 91.58
ACO #4 Access to Specialists 88.07 85.11 87.91 85.12 86.84 83.97
ACO #5 Health Promotion and Education 56.87 56.61 59.86 58.38 58.8 58.29
ACO #6 Shared Decision Making 72.57 73.99 75.57 74.53 75.06 74.6
ACO #7 Health Status/Functional Status 68.58 70.35 71.08 71.12 71.42 71.1
ACO #8 Risk Standardized, All Condition Readmissions 14.78 15.42 14.57 14.9 14.99 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 0.9 1.13 1.07 1.17 0.85 1.08
ACO #10 ASC Admission: Heart Failure 1.33 1.09 1.26 1.2 1.26 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment 92.11% 25.70% 86.00% 66.21% 94.64% 76.71%
ACO #12 Medication Reconciliation 0.19 72.37 24.59 73.56 69.29 82.61
ACO #13 Falls: Screening for Fall Risk 2.3 28.27 45.67 39.57 58.54 45.6
ACO #14 Influenza Immunization 60.76 50.58 68.66 56.93 69.36 57.51
ACO #15 Pneumococcal Vaccination 47.39 48.62 64.82 54.76 58.01 55.03
ACO #16 Adult Weight Screening and Follow-up 81.04 53.91 71.29 61.61 86.2 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention 96.18 80.12 97.84 84.01 97.83 86.79
ACO #18 Depression Screening 0.23 22.48 38.75 31.19 56.2 39.27
ACO #19 Colorectal Cancer Screening 50.69 50.21 74.58 59.3 65.62 56.14
ACO #20 Mammography Screening 52.72 62.23 59.08 62.05 70.07 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years 0 71.56 50.2 74.25 51.05 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) 80.74 N/A 86.33 N/A 82.73 N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) 57.31 N/A 63.31 N/A N/A N/A
ACO #24 Blood Pressure (BP) <140/90 73.09 N/A 74.34 N/A 66.91 N/A
ACO #25 Tobacco Non Use 88.86 N/A 90.17 N/A 88.08 N/A
ACO #26 Asprin Use 72.86 N/A 86.42 N/A 86.14 N/A
ACO #27 Percent of Beneficiaries with Diabetes whose HbA1c in poor control (>9 percent) 13.92% 25.94% 7.43% 22.11% 8.74% 20.35%
ACO #28 Percent of Beneficiaries with Hypertension whose BP <140/90 71.28% 63.22% 80.19% 67.79% 64.32% 68.02%
ACO #29 Percent of Beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl 59.04% 52.02% 64.90% 55.44% N/A N/A
ACO #30 Percent of Beneficiaries with IVD who use Asprin ir other Antithrombotic 79.08% 72.60% 84.76% 76.35% 86.49% 80.79%
ACO #31 Beta-Blocker Therapy for LVSD 70.83 79.60 90.79 79.82 88.89 82.71%
ACO #32 Drug Therapy for Lowering LDL Cholesterol 78.95 N/A 82.41 N/A N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD

For more information on how to interpret scores on the above quality performance measures, see
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/downloads/MSSP-QM-Benchmarks.pdf